[
  {
    "text": "1.31 \"Gross to Net Fraction\" shall mean, for each SKU of the Product, a fraction (i) the numerator of which is the net",
    "bbox": [
      179,
      141,
      1000,
      156
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "sales of the SKU of the Product in the Territory for an applicable period (based on the gross-to-net discounts for all sales of such",
    "bbox": [
      112,
      162,
      1000,
      176
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "SKU of the Product (i.e., sales attributable to the Specialty, as well as all other sales of such SKU of the Product), and (ii) the",
    "bbox": [
      111,
      180,
      1000,
      195
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "denominator of which is gross sales of such SKU of the Product in the Territory for an applicable period, in each case, as",
    "bbox": [
      110,
      199,
      1000,
      215
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "determined in accordance with Dova's revenue recognition policies, which is in accordance with GAAP (on a consistent basis), for",
    "bbox": [
      114,
      220,
      1000,
      232
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "quarterly financial reporting purposes, as reported in Dova's quarterly filings with the U.S. Securities Exchange Commission.",
    "bbox": [
      114,
      239,
      1000,
      253
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.32 \"Indemnified Party'' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      181,
      273,
      813,
      286
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.33 \"Indemnifying Party' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      180,
      308,
      825,
      323
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.34 \"Intellectual Property\" shall have the meaning set forth in Section 8.1.2",
    "bbox": [
      179,
      344,
      847,
      359
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.35 \"Intermediary\" shall mean any wholesaler or distributor who sells Product to Retail Pharmacies and Non-Retail",
    "bbox": [
      181,
      381,
      1000,
      395
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Institutions, but not patients, and with which Dova (or its Affiliates) has entered into an agreement or otherwise has arrangements.",
    "bbox": [
      112,
      400,
      1000,
      415
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.36 \"Inventions\"' shall have the meaning set forth in Section 8.1.2.",
    "bbox": [
      181,
      435,
      752,
      449
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.37 \"JSC\" shall have the meaning set forth in Section 3.1.",
    "bbox": [
      181,
      471,
      677,
      485
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.38 \"Know-How\"' shall mean information, whether or not in written form, including biological, chemical, pharmacological,",
    "bbox": [
      179,
      507,
      1000,
      522
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "toxicological, medical or clinical, analytical, quality, manufacturing, research, or sales and marketing information, including",
    "bbox": [
      112,
      527,
      1000,
      543
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "processes, methods, procedures, techniques, plans, programs and data.",
    "bbox": [
      113,
      547,
      719,
      561
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.39 \"Losses\" shall mean any and all amounts paid or payable to Third Parties with respect to a Claim (including any and.",
    "bbox": [
      179,
      581,
      1000,
      596
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "all losses, damages, obligations, liabilities, fines, fees, penalties, awards, judgments, interest), together with all documented out-of-",
    "bbox": [
      114,
      602,
      1000,
      616
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "pocket costs and expenses, including attorney's fees, reasonably incurred..",
    "bbox": [
      112,
      620,
      738,
      635
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.40 *Net Sales\"' shall mean, for an applicable period, the aggregate amount, without duplication, equal to the Specialty",
    "bbox": [
      179,
      655,
      1000,
      671
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Pharmacy Net Sales for each SKU, the Retail Net Sales for each SKU, if any, and the Non-Retail Net Sales for each SKU.",
    "bbox": [
      113,
      675,
      1000,
      689
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.41 *Non-Retail Institution' shall mean any institution (other than the Specialty Pharmacies, Retail Pharmacies and",
    "bbox": [
      179,
      710,
      1000,
      724
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Intermediaries) to which Dova (or its Affiliates or its Intermediaries) sells and/or ships units of Product during the Term, which shall",
    "bbox": [
      112,
      731,
      1000,
      744
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "include group purchasing organizations (GPOs), hospitals, clinics, long term care facilities and any outlets that are a member of an",
    "bbox": [
      111,
      749,
      1000,
      764
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Integrated Delivery Network (IDN), and with which Dova or its Affiliates do not have data agreements which enables Dova to",
    "bbox": [
      113,
      770,
      1000,
      782
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "track shipments of Product from such institution to patients based on the Target Professional prescribing such Product.",
    "bbox": [
      114,
      788,
      1000,
      801
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.42 \"Non-Retail Net Sales'' shall mean, for each SKU of the Product:.",
    "bbox": [
      181,
      822,
      797,
      835
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED",
    "bbox": [
      149,
      949,
      1000,
      960
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION",
    "bbox": [
      415,
      964,
      917,
      971
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      593,
      1000
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1.31 \"Gross to Net Fraction\" shall mean, for each SKU of the Product, a fraction (i) the numerator of which is the net",
    "bbox": [
      179,
      141,
      1000,
      156
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "sales of the SKU of the Product in the Territory for an applicable period (based on the gross-to-net discounts for all sales of such",
    "bbox": [
      112,
      162,
      1000,
      176
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "SKU of the Product (i.e., sales attributable to the Specialty, as well as all other sales of such SKU of the Product), and (ii) the",
    "bbox": [
      111,
      180,
      1000,
      195
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "denominator of which is gross sales of such SKU of the Product in the Territory for an applicable period, in each case, as",
    "bbox": [
      110,
      199,
      1000,
      215
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "determined in accordance with Dova's revenue recognition policies, which is in accordance with GAAP (on a consistent basis), for",
    "bbox": [
      114,
      220,
      1000,
      232
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "quarterly financial reporting purposes, as reported in Dova's quarterly filings with the U.S. Securities Exchange Commission.",
    "bbox": [
      114,
      239,
      1000,
      253
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.32 \"Indemnified Party'' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      181,
      273,
      813,
      286
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.33 \"Indemnifying Party' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      180,
      308,
      825,
      323
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.34 \"Intellectual Property\" shall have the meaning set forth in Section 8.1.2",
    "bbox": [
      179,
      344,
      847,
      359
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.35 \"Intermediary\" shall mean any wholesaler or distributor who sells Product to Retail Pharmacies and Non-Retail",
    "bbox": [
      181,
      381,
      1000,
      395
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Institutions, but not patients, and with which Dova (or its Affiliates) has entered into an agreement or otherwise has arrangements.",
    "bbox": [
      112,
      400,
      1000,
      415
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.36 \"Inventions\"' shall have the meaning set forth in Section 8.1.2.",
    "bbox": [
      181,
      435,
      752,
      449
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.37 \"JSC\" shall have the meaning set forth in Section 3.1.",
    "bbox": [
      181,
      471,
      677,
      485
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.38 \"Know-How\"' shall mean information, whether or not in written form, including biological, chemical, pharmacological,",
    "bbox": [
      179,
      507,
      1000,
      522
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "toxicological, medical or clinical, analytical, quality, manufacturing, research, or sales and marketing information, including",
    "bbox": [
      112,
      527,
      1000,
      543
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "processes, methods, procedures, techniques, plans, programs and data.",
    "bbox": [
      113,
      547,
      719,
      561
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.39 \"Losses\" shall mean any and all amounts paid or payable to Third Parties with respect to a Claim (including any and.",
    "bbox": [
      179,
      581,
      1000,
      596
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "all losses, damages, obligations, liabilities, fines, fees, penalties, awards, judgments, interest), together with all documented out-of-",
    "bbox": [
      114,
      602,
      1000,
      616
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "pocket costs and expenses, including attorney's fees, reasonably incurred..",
    "bbox": [
      112,
      620,
      738,
      635
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.40 *Net Sales\"' shall mean, for an applicable period, the aggregate amount, without duplication, equal to the Specialty",
    "bbox": [
      179,
      655,
      1000,
      671
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Pharmacy Net Sales for each SKU, the Retail Net Sales for each SKU, if any, and the Non-Retail Net Sales for each SKU.",
    "bbox": [
      113,
      675,
      1000,
      689
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.41 *Non-Retail Institution' shall mean any institution (other than the Specialty Pharmacies, Retail Pharmacies and",
    "bbox": [
      179,
      710,
      1000,
      724
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Intermediaries) to which Dova (or its Affiliates or its Intermediaries) sells and/or ships units of Product during the Term, which shall",
    "bbox": [
      112,
      731,
      1000,
      744
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "include group purchasing organizations (GPOs), hospitals, clinics, long term care facilities and any outlets that are a member of an",
    "bbox": [
      111,
      749,
      1000,
      764
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Integrated Delivery Network (IDN), and with which Dova or its Affiliates do not have data agreements which enables Dova to",
    "bbox": [
      113,
      770,
      1000,
      782
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "track shipments of Product from such institution to patients based on the Target Professional prescribing such Product.",
    "bbox": [
      114,
      788,
      1000,
      801
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.42 \"Non-Retail Net Sales'' shall mean, for each SKU of the Product:.",
    "bbox": [
      181,
      822,
      797,
      835
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED",
    "bbox": [
      149,
      949,
      1000,
      960
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION",
    "bbox": [
      415,
      964,
      917,
      971
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      593,
      1000
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.31 \"Gross to Net Fraction\" shall mean, for each SKU of the Product, a fraction (i) the numerator of which is the net",
    "bbox": [
      179,
      141,
      1000,
      156
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "sales of the SKU of the Product in the Territory for an applicable period (based on the gross-to-net discounts for all sales of such",
    "bbox": [
      112,
      162,
      1000,
      176
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SKU of the Product (i.e., sales attributable to the Specialty, as well as all other sales of such SKU of the Product), and (ii) the",
    "bbox": [
      111,
      180,
      1000,
      195
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "denominator of which is gross sales of such SKU of the Product in the Territory for an applicable period, in each case, as",
    "bbox": [
      110,
      199,
      1000,
      215
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "determined in accordance with Dova's revenue recognition policies, which is in accordance with GAAP (on a consistent basis), for",
    "bbox": [
      114,
      220,
      1000,
      232
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "quarterly financial reporting purposes, as reported in Dova's quarterly filings with the U.S. Securities Exchange Commission.",
    "bbox": [
      114,
      239,
      1000,
      253
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.32 \"Indemnified Party'' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      181,
      273,
      813,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.33 \"Indemnifying Party' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      180,
      308,
      825,
      323
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.34 \"Intellectual Property\" shall have the meaning set forth in Section 8.1.2",
    "bbox": [
      179,
      344,
      847,
      359
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.35 \"Intermediary\" shall mean any wholesaler or distributor who sells Product to Retail Pharmacies and Non-Retail",
    "bbox": [
      181,
      381,
      1000,
      395
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Institutions, but not patients, and with which Dova (or its Affiliates) has entered into an agreement or otherwise has arrangements.",
    "bbox": [
      112,
      400,
      1000,
      415
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.36 \"Inventions\"' shall have the meaning set forth in Section 8.1.2.",
    "bbox": [
      181,
      435,
      752,
      449
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.37 \"JSC\" shall have the meaning set forth in Section 3.1.",
    "bbox": [
      181,
      471,
      677,
      485
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.38 \"Know-How\"' shall mean information, whether or not in written form, including biological, chemical, pharmacological,",
    "bbox": [
      179,
      507,
      1000,
      522
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "toxicological, medical or clinical, analytical, quality, manufacturing, research, or sales and marketing information, including",
    "bbox": [
      112,
      527,
      1000,
      543
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "processes, methods, procedures, techniques, plans, programs and data.",
    "bbox": [
      113,
      547,
      719,
      561
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.39 \"Losses\" shall mean any and all amounts paid or payable to Third Parties with respect to a Claim (including any and.",
    "bbox": [
      179,
      581,
      1000,
      596
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "all losses, damages, obligations, liabilities, fines, fees, penalties, awards, judgments, interest), together with all documented out-of-",
    "bbox": [
      114,
      602,
      1000,
      616
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "pocket costs and expenses, including attorney's fees, reasonably incurred..",
    "bbox": [
      112,
      620,
      738,
      635
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.40 *Net Sales\"' shall mean, for an applicable period, the aggregate amount, without duplication, equal to the Specialty",
    "bbox": [
      179,
      655,
      1000,
      671
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Pharmacy Net Sales for each SKU, the Retail Net Sales for each SKU, if any, and the Non-Retail Net Sales for each SKU.",
    "bbox": [
      113,
      675,
      1000,
      689
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.41 *Non-Retail Institution' shall mean any institution (other than the Specialty Pharmacies, Retail Pharmacies and",
    "bbox": [
      179,
      710,
      1000,
      724
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Intermediaries) to which Dova (or its Affiliates or its Intermediaries) sells and/or ships units of Product during the Term, which shall",
    "bbox": [
      112,
      731,
      1000,
      744
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "include group purchasing organizations (GPOs), hospitals, clinics, long term care facilities and any outlets that are a member of an",
    "bbox": [
      111,
      749,
      1000,
      764
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Integrated Delivery Network (IDN), and with which Dova or its Affiliates do not have data agreements which enables Dova to",
    "bbox": [
      113,
      770,
      1000,
      782
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "track shipments of Product from such institution to patients based on the Target Professional prescribing such Product.",
    "bbox": [
      114,
      788,
      1000,
      801
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.42 \"Non-Retail Net Sales'' shall mean, for each SKU of the Product:.",
    "bbox": [
      181,
      822,
      797,
      835
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED",
    "bbox": [
      149,
      949,
      1000,
      960
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION",
    "bbox": [
      415,
      964,
      917,
      971
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      593,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.31 \"Gross to Net Fraction\" shall mean, for each SKU of the Product, a fraction (i) the numerator of which is the net",
    "bbox": [
      179,
      141,
      1000,
      156
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "sales of the SKU of the Product in the Territory for an applicable period (based on the gross-to-net discounts for all sales of such",
    "bbox": [
      112,
      162,
      1000,
      176
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SKU of the Product (i.e., sales attributable to the Specialty, as well as all other sales of such SKU of the Product), and (ii) the",
    "bbox": [
      111,
      180,
      1000,
      195
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "denominator of which is gross sales of such SKU of the Product in the Territory for an applicable period, in each case, as",
    "bbox": [
      110,
      199,
      1000,
      215
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "determined in accordance with Dova's revenue recognition policies, which is in accordance with GAAP (on a consistent basis), for",
    "bbox": [
      114,
      220,
      1000,
      232
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "quarterly financial reporting purposes, as reported in Dova's quarterly filings with the U.S. Securities Exchange Commission.",
    "bbox": [
      114,
      239,
      1000,
      253
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.32 \"Indemnified Party'' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      181,
      273,
      813,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.33 \"Indemnifying Party' shall have the meaning set forth in Section 11.3..",
    "bbox": [
      180,
      308,
      825,
      323
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.34 \"Intellectual Property\" shall have the meaning set forth in Section 8.1.2",
    "bbox": [
      179,
      344,
      847,
      359
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.35 \"Intermediary\" shall mean any wholesaler or distributor who sells Product to Retail Pharmacies and Non-Retail",
    "bbox": [
      181,
      381,
      1000,
      395
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Institutions, but not patients, and with which Dova (or its Affiliates) has entered into an agreement or otherwise has arrangements.",
    "bbox": [
      112,
      400,
      1000,
      415
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.36 \"Inventions\"' shall have the meaning set forth in Section 8.1.2.",
    "bbox": [
      181,
      435,
      752,
      449
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.37 \"JSC\" shall have the meaning set forth in Section 3.1.",
    "bbox": [
      181,
      471,
      677,
      485
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.38 \"Know-How\"' shall mean information, whether or not in written form, including biological, chemical, pharmacological,",
    "bbox": [
      179,
      507,
      1000,
      522
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "toxicological, medical or clinical, analytical, quality, manufacturing, research, or sales and marketing information, including",
    "bbox": [
      112,
      527,
      1000,
      543
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "processes, methods, procedures, techniques, plans, programs and data.",
    "bbox": [
      113,
      547,
      719,
      561
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.39 \"Losses\" shall mean any and all amounts paid or payable to Third Parties with respect to a Claim (including any and.",
    "bbox": [
      179,
      581,
      1000,
      596
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "all losses, damages, obligations, liabilities, fines, fees, penalties, awards, judgments, interest), together with all documented out-of-",
    "bbox": [
      114,
      602,
      1000,
      616
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "pocket costs and expenses, including attorney's fees, reasonably incurred..",
    "bbox": [
      112,
      620,
      738,
      635
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.40 *Net Sales\"' shall mean, for an applicable period, the aggregate amount, without duplication, equal to the Specialty",
    "bbox": [
      179,
      655,
      1000,
      671
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Pharmacy Net Sales for each SKU, the Retail Net Sales for each SKU, if any, and the Non-Retail Net Sales for each SKU.",
    "bbox": [
      113,
      675,
      1000,
      689
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.41 *Non-Retail Institution' shall mean any institution (other than the Specialty Pharmacies, Retail Pharmacies and",
    "bbox": [
      179,
      710,
      1000,
      724
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Intermediaries) to which Dova (or its Affiliates or its Intermediaries) sells and/or ships units of Product during the Term, which shall",
    "bbox": [
      112,
      731,
      1000,
      744
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "include group purchasing organizations (GPOs), hospitals, clinics, long term care facilities and any outlets that are a member of an",
    "bbox": [
      111,
      749,
      1000,
      764
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Integrated Delivery Network (IDN), and with which Dova or its Affiliates do not have data agreements which enables Dova to",
    "bbox": [
      113,
      770,
      1000,
      782
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "track shipments of Product from such institution to patients based on the Target Professional prescribing such Product.",
    "bbox": [
      114,
      788,
      1000,
      801
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.42 \"Non-Retail Net Sales'' shall mean, for each SKU of the Product:.",
    "bbox": [
      181,
      822,
      797,
      835
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED",
    "bbox": [
      149,
      949,
      1000,
      960
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION",
    "bbox": [
      415,
      964,
      917,
      971
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018",
    "bbox": [
      133,
      1000,
      593,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  }
]